Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Former Moderna executive Dr Melanie Ivarsson has been named chief executive of the UK Health Data Research Service, a £600 million government‑backed unit that will create a secure, single gateway to NHS health data. The HDRS, based at the Wellcome Genome Campus, is set to begin operations in December and will streamline data access for both academic and commercial researchers. In parallel, the BioIndustry Association announced Prof Chris Molloy as its new CEO, bringing three decades of life‑science experience from the Medicines Discovery Catapult. Both appointments signal a coordinated push to turn the UK’s rich health data into faster drug development and biotech growth.
A study in *Materials* shows that copper nanoparticles produced via a beetroot‑based green synthesis exhibit markedly stronger antimicrobial activity when embedded in polypropylene than both silver‑based composites and chemically reduced copper. The green‑synthesized copper particles are smaller, less prone to...
Researchers at McMaster University, in partnership with Espervita Therapeutics, reported preclinical data showing that the small‑molecule EVT0185 can both prevent and reverse liver fibrosis in mouse models of metabolic dysfunction‑associated steatohepatitis (MASH). The compound simultaneously inhibits the enzymes ACLY and...
Nabla Bio, a Harvard spin‑out founded in 2020, is developing an AI‑driven platform that automatically completes biologics designs while preserving manufacturability. The technology, created in George Church’s lab, targets the persistent bottleneck of translating complex protein candidates into scalable therapeutics....
Scientists have developed a technique to 3D‑print micrometer‑scale structures inside living cells using a light‑sensitive photoresist and two‑photon laser polymerization. The method achieves sub‑micron resolution, allowing shapes such as barcodes, geometric patterns, and a miniature elephant to be fabricated intracellularly....
A recent study highlights astaxanthin’s antioxidant properties in mitigating exercise‑induced muscle damage. Participants who took a daily 12 mg dose experienced lower oxidative stress markers and reported faster recovery from soreness. The research covered both endurance and resistance training protocols, showing...
AI‑driven virtual scientists are moving from prototype to production as Potato’s AI agent, Tater, replicated a core neuroscience finding and pinpointed SARS‑CoV‑2 protease mutations within hours. The company closed a $4.5 million seed round and partnered with Wiley to ingest peer‑reviewed...
Genomics is shifting from manual, bottlenecked processes to automated, modular workflows that can keep pace with rapidly evolving assays. Companies such as Opentrons, 10x Genomics, and SPT Labtech are delivering flexible robotic platforms that reconfigure library‑prep and single‑cell pipelines on...
Antibody‑drug conjugates (ADCs) are reshaping oncology, but their structural heterogeneity creates demanding bioanalytical and pharmacokinetic challenges. WuXi AppTec’s DMPK leaders stress that precise drug‑to‑antibody ratio (DAR) measurement, payload release profiling, and biotransformation mapping are essential across development stages. They recommend...
Haha. Yes was lucky to be on a panel today w/ Deputy Secretary Jim O'Neill about how to keep the US competitive with biotech in China. Short answer: replace US lab benches with autonomous labs. (And fix our clinical...
It’s not AI, JPM or anything to do with the Bay Area so probably no-one left on this site cares, but here is some new #synbio Engineered Living Materials work from our lab @ImperialBioeng and the Hub for Biotech in...
Novartis chief strategy officer Ronny Gal told BioSpace at J.P. Morgan that the Swiss giant will not pursue a GLP‑1 acquisition, citing the high commercial risk of me‑too products. He emphasized that existing GLP‑1s such as Eli Lilly’s Zepbound and Novo Nordisk’s...
Researchers at Karolinska Institutet discovered that CD4+ T cells targeting Epstein‑Barr virus (EBV) protein EBNA1 also recognize the brain protein Anoctamin‑2 (ANO2), providing mechanistic evidence linking EBV infection to multiple sclerosis (MS). In blood samples, about 57% of untreated MS...
Researchers introduced Matrix‑Inverse Targeting (MINT) nanoparticles that exploit cartilage matrix changes to deliver RNA therapeutics directly to osteoarthritic lesions. The particles sense lesion severity, releasing siRNA or mRNA only in damaged zones, which in animal models halted cartilage degeneration and...
Researchers at Kanazawa University and collaborators uncovered a hidden activation mechanism for the Met receptor, showing that hepatocyte growth factor (HGF) binding to the membrane‑distal Sema domain drives dimerization of the membrane‑proximal IPT4 domains. Using in‑cell cross‑linking, high‑speed atomic force...
A recent peer‑reviewed study uncovers novel molecular mechanisms behind olig oasthenozoospermia, the condition characterized by low sperm count and poor motility. Researchers identified mitochondrial DNA deletions and altered microRNA expression as key contributors, and demonstrated that antioxidant therapy partially restores sperm...
Brazilian researchers have created biodegradable starch sachets reinforced with copper‑zeolite nanoparticles to deliver granular fertilizers in a controlled manner. The sachets release nutrients gradually, reducing leaching and volatilization while offering antimicrobial protection against soil fungi. Mechanical strength peaks at 3 %...
In this episode, Wendy Powell, founder of the MUTU System, discusses how her digitally delivered pelvic health platform achieved clinical validation and delivers measurable improvements in core and pelvic floor function for women. She explains the rigorous validation process, the...
Purdue University engineers have unveiled IsoHeat, a portable water‑bath system that powers loop‑mediated isothermal amplification (LAMP) assays for rapid pathogen detection. The device reaches the required 65 °C in roughly 12 minutes—about one‑third the time of a leading commercial precision cooker—while...
The FDA has extended its review of Travere Therapeutics’ kidney‑disorder drug by three months, pushing the expected decision past today’s deadline. The agency’s delay pertains to a pending label expansion for a rare renal condition, which could broaden the drug’s...
Indonesian researchers have demonstrated that a standardized propolis extract markedly reduces diet‑induced liver inflammation in a mouse model. The study showed significant drops in pro‑inflammatory cytokines such as TNF‑α and IL‑6 without observable toxicity. Findings suggest the extract could serve...
Two biotech firms announced phase‑3 oncology trials in San Francisco, enrolling fewer than 20 and fewer than 50 patients respectively. The ultra‑small cohorts reflect a growing trend to accelerate drug development for rare cancers, leveraging expedited regulatory pathways. While the approach...
Cyanobacteria have been shown to import and metabolize guanidine, using it as their sole nitrogen source. The study identified a high‑affinity ABC transporter, a guanidine hydrolase, and a riboswitch that together regulate uptake, degradation, and efflux. These mechanisms are widespread...
Single-use systems (SUS) are becoming integral to cell and gene therapy (CGT) manufacturing, offering pre‑sterilized, disposable components that eliminate cleaning validation and enable fast changeovers for low‑volume, high‑value products. Automation and modular platforms are now being paired with SUS to...
Pharma leaders say 2026 will be defined by the rise of agentic AI, sustainable manufacturing, and resilient, regionalized supply chains. AI agents are moving from pilot projects to embedded decision‑making in drug discovery, process optimization and digital twins, slashing timelines...
The 2026 policy outlook warns that the turbulence of 2025 is giving way to a deeper, more systemic shift in U.S. biomedical policy. Political and ideological forces are increasingly dictating drug‑pricing rules and regulatory decisions, eroding the traditional science‑based framework....
The U.S. Food and Drug Administration has asked manufacturers of six seasonal influenza vaccines to revise their product labels to explicitly mention the risk of febrile seizures. The directive follows emerging safety data linking certain flu shots, especially those administered...
Recent research underscores that obesity not only raises breast cancer incidence but also worsens prognosis across tumor subtypes. Excess adipose tissue fuels estrogen production, chronic inflammation, and insulin resistance, creating a microenvironment that promotes tumor growth and metastasis. Clinical data...
Recent research highlights the gut‑brain axis as a key factor in Parkinson’s disease, where age‑related dysbiosis may exacerbate neurodegeneration. Small clinical trials of fecal microbiota transplantation (FMT) have shown restored microbial balance, reduced constipation, and measurable improvements in motor, cognitive,...
The FDA has asked Eli Lilly and Novo Nordisk to remove suicide‑related warnings from the labels of their GLP‑1 weight‑loss drugs. The warning, added in 2022 after isolated case reports, is being reconsidered following a thorough review of post‑marketing data. The agency...
The U.S. Department of Health and Human Services removed several members from the Vaccine Injury Compensation Program’s advisory committee, signaling a significant reshaping of the panel. The ousted members were appointed during the previous administration and faced criticism for their...
Charles River Laboratories exercised its option to buy the remaining 79% of PathoQuest for roughly $60 million, completing its 2018 investment. The Paris‑based firm brings next‑generation sequencing (NGS) capabilities that accelerate in‑vitro GMP and non‑GMP biologics testing while supporting alternative methods...
The U.S. Department of Commerce has reportedly concluded its Section 232 investigation into pharmaceutical imports, effectively ending the Trump administration’s trade probe. The decision means no new tariffs will be levied on foreign‑made medicines, averting a potential price shock for...
The targeting chimera (TAC) platform is shifting from early‑stage proof‑of‑concept to broader industry adoption as 2026 approaches. Companies are deploying next‑generation E3 ligases, cell‑surface degrader formats, and non‑proteolytic proximity mechanisms to expand target space beyond intracellular proteins. These advances promise...
Researchers at the University of Bonn’s PhenoRob Cluster argue that Europe’s agriculture must shift from isolated fixes to a unified, vision‑led innovation system. Their paper in Agricultural Systems outlines how coordinated technology, business models, and policy reforms can make farming...
The episode explores the "consumer frontier"—the point where technology becomes culture—as it shifts from software to hardware (atoms) and then to biology (cells). It explains how lowering technological difficulty and rising cultural readiness have turned software into pop culture, and...
Treosulfan (Grafapex®) received FDA approval in 2025 when combined with fludarabine as a conditioning regimen for allogeneic stem‑cell transplantation (alloHSCT) in patients aged one year and older with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The approval follows trials...
VantAI, a Roivant‑incubated AI drug‑discovery startup, closed an $80 million seed round and announced a rebrand to Proxima. The funding, led by existing backers, is intended to accelerate its proprietary AI platform for early‑stage therapeutics. The round underscores growing investor appetite...
OpenAI’s accelerating pace of model development is prompting businesses to reconsider direct competition. Companies are weighing whether to build in‑house AI, partner with OpenAI, or adopt alternative strategies. The debate intensifies as OpenAI’s products become more embedded in enterprise workflows,...
Russian researchers from Tomsk Polytechnic and Surgut State Universities have demonstrated a microfluidic technique that encapsulates thyme extract in gelatin‑alginate nanodroplets within an oil carrier. The process creates self‑regulating nanodoses, preventing rapid evaporation and skin irritation associated with raw thyme...
Japanese researchers have documented the first morphological anomalies in the tick species Haemaphysalis megaspinosa, publishing detailed findings in Acta Parasitologica. The study reports malformed legs, irregular scutum patterns, and atypical mouthpart development, challenging the long‑held view of the species' morphological...
Digital health funding jumped to $14.2 billion in 2025, the highest level since 2022, driven largely by artificial‑intelligence startups. AI‑focused firms secured 54% of total capital and enjoyed a 19% premium in average deal size versus non‑AI peers. Although the total...
Conducting interviews on stage can be emotional. Last night I got to speak with Richard Pazdur, the long-time FDA cancer czar who recently retired, along @ScottGottlieb and former FDA official Julie Tierney. Pazdur changed the way medicines are regulated, getting them...
Concurrent improvements in physical activity (MVPA), sleep, and diet are associated with meaningful improvements in healthspan (DFLE) and lifespan LD-low quality diet, MD-moderate, HD-high New @eClinicalMed, @uk_biobank 59,000 participants w/ 8 year follow-up https://t.co/gl36VSQVFh
PD(L1)xVEGF the Keytruda replacement? The deal making market is clearly not pricing it that way. 🗣️“We want exposure to a hot mechanism, but we want most of the price contingent on Phase 2/3 and commercial proof.” Great analysis below...
The brain's glucose metabolism, cognition, and aging: "Variability in the moment-to-moment metabolism of glucose is biologically and functionally important to cognition and in explaining metabolic and brain network changes in aging." https://t.co/0cFbXJFQD5 https://t.co/sCO98PHBL0
Incorporating Probability of Success (PoS) is a unique aspect of #biotech valuation investors must be aware of. It tries to factor development risk into revenue and cost assumptions. Here is a table of PoS values: #learnbiotechinvesting #investing #BiotechPrometheus https://t.co/Sv8XodkWXg
A fasting-mimicking diet improved the clinical course and suppressed inflammation in people with mild or moderate Crohn's disease in a randomized trial https://t.co/pVVJ4HD4gD https://t.co/2PyJObeAqQ
Fat surrounding the large intestine (epiploic) is rich in immune cells and can drive inflammation. Study in people with severe obesity. @Cell_Metabolism https://t.co/kN1B77XrCm https://t.co/YlNrpCGZjI
3 new reports @CellCellPress on the mechanistic underpinnings of multiple sclerosis and Epstein-Barr virus involvement https://t.co/JXThwhZugq https://t.co/fO1aDsZmmB https://t.co/fO1aDsZmmB https://t.co/eUNrrRGw0s
